No abstract

No abstract

No abstract

Discovering and developing new drug is an arduous, costly and risky process. Drug repositioning, by discovering new indications of old drugs out of their original indications, is a time-saving, cost-efficient and low-risk manner. This made it more and more important in drug discovery and development. It has appeared numerous methods for drug repositioning in recent years. Combining the information of interactions between drugs and targets with omics data is a reasonable and effectively approach of drug repositioning. Dozens of databases including information of drug targets were constructed with varying scopes by different research groups in the past decade. However, it is inconvenient to researchers who need such information because of the lack of coordination in naming rules among these databases and the existed data omissions or redundancies. So we create a new database of drug-target interactions by manually inspecting and standardizing the data collected from these databases and scientific literatures. In the current version, there are 766 drug/compound entries, 746 target entries and 2862 items of drug-target interactions in the database. It will facilitate researchers to get the information of drug targets easily and quickly, providing clues for drug repositioning.